Vaccines are an especially risky proposition for pharmaceutical manufacturers since the costs are higher than for other types of drugs and demand could drop drastically once a crisis is over.
By
MIT study explores the key factors behind patient outcomes in clinical trials evaluating new treatments for non-small-cell lung cancer.
By
The studies describe new methods for accelerating drug approvals during pandemics and for providing more accurate measures of the probabilities of success for clinical trials of vaccines.
By
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
An updated and expanded version of the “Work Design for Health” employer toolkit—developed by researchers from the Harvard T.H. Chan School of Public Health and the MIT Sloan School of Management—has been launched.
By
The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence announced a new initiative, Project ALPHA (Analytics for Life-sciences Professionals and Healthcare Advocates).
A new “Work Design for Health” framework and employer toolkit—developed by researchers from Harvard T.H. Chan School of Public Health and the Institute for Work and Employment Research at the MIT Sloan School of Management—map how to create work environments that foster worker health and well-being.
Researchers launched an in-house Data Science and Artificial Intelligence (DSAI) challenge to beat MIT’s machine-learning models for predicting clinical trial outcomes. The results are now available.
MIT Sloan has hundreds of seminars every semester bringing in the world’s leading experts on topics from sustainability to finance. Find out more.
By
In this article, MIT Sloan Professor Katherine Kellogg and a team of coauthors describe a project they have been working on involving the use of a specialized online jobs platform to bring new job applicants to open positions at skilled nursing facilities in Massachusetts during the COVID-19 pandemi...
